Mammalian sex-determination and differentiation are controlled by several genes, such as Sry, Sox-9, Dax-1 and Mullerian inhibiting substance (MIS), but their upstream and downstream genes are largely unknown. Ad4BP/SF-1, encoding a zinc ®nger transcription factor, plays important roles in gonadogenesis. Disruption of this gene caused disappearance of the urogenital system including the gonad. Ad4BP/ SF-1, however, is also involved in the sex differentiation of the gonad at later stages, such as the regulation of steroid hormones and MIS. Pod-1/Capsulin, a member of basic helix±loop±helix transcription factors, is expressed in a pattern closely related but mostly complimentary to that of the Ad4BP/SF-1 expression in the developing gonad. In the co-transfection experiment using cultured cells, overexpression of Pod-1/Capsulin repressed expression of a reporter gene that carried the upstream regulatory region of the Ad4BP/SF-1 gene. Furthermore, forced expression of Pod-1/Capsulin repressed expression of Ad4BP/SF-1 in the Leydig cell-derived I-10 cells. These results suggest that Pod-1/ Capsulin may play important roles in the development and sex differentiation of the mammalian gonad via transcriptional regulation of Ad4BP/SF-1. q
Introduction
Sex differentiation of the male mouse gonad becomes distinguishable by appearance of testis cords at 12.5 days post coitum (dpc), followed by mitotic arrest of germ cells in the testis beginning at 13.5 dpc. Male somatic cells in the fetal testis direct germ cells into the prospermatogonia differentiation, whereas they enter into meiosis in the fetal ovary. The initial step of sex differentiation is controlled by Sry expression in precursors of Sertoli cells of the male gonad at 10.5±11.5 dpc (Koopman et al., 1990; Sinclair et al., 1990; Hacker et al., 1995) . A Sry transgene can initiate the whole events leading to testis differentiation, although other genes on the Y chromosome are required for spermatogenesis (Koopman et al., 1991) .
Since the discovery of Sry, a nuclear transcription factor, as the testis-determining gene, vigorous attempts have been made to ®nd gene cascades which should play important roles not only in the differentiation of testis somatic tissues but also the male germ cells. However, only a limited number of genes have been identi®ed, and there should be still many molecular and cellular aspects remaining to be clari®ed for full understanding of mammalian sex differentiation. The SRY protein contains a DNA-binding domain, HMG box. Identi®cation of the HMG box triggered isolation of many related genes, Sox gene family, which have similar HMG boxes. Among them, Sox9 is an important gene involved in sex-determination and is the responsive gene of human genetic diseases that show sex differentiation abnormality in addition to skeletal anomalies (Foster et al., 1994; Wagner et al., 1994) . Sox9 is expressed from early stages of sexdetermination as well as Sry. Moreover, sex-related expression of Sox-9 is observed not only in mammals but also in avian, suggesting that Sox9 may be the oldest male-determining gene in the vertebrates (Kent et al., 1996; Morais da Silva et al., 1996) , and that Sry may have appeared later and taken the initiation role in the mammals.
Besides the Sry and Sox9, genes so far identi®ed in relation to gonadal development can be classi®ed into three groups. Firstly, there are genes, such as a zinc-®nger transcription factor gene, Wilms' tumor 1 (WT-1), and a steroidogenic transcription factor gene, Ad4BP/SF-1, which are expressed during the early stages of development of both the male and female urogenital system (Pelletier et al., 1991; Ikeda et al., 1994) . Disruption of the genes caused disappearance of the whole urogenital system including the gonad (Kreidberg et al., 1993; Luo et al., 1994) . Ad4BP/ SF-1, however, is also involved in the sex differentiation of the gonad at later stages, such as the regulation of steroid hormones Ikeda et al., 1993; Morohashi et al., 1993) . Secondly, a few genes are expressed in sexdependent manners during sex-determination at the same time as Sry and Sox9. An orphan-receptor-type transcription factor gene, Dax-1, located on the X chromosome is such a gene, and its dosage alteration is involved in the abnormalities of sex differentiation in the human Muscatelli et al., 1994) . A recent study using transgenic mice con®rmed that its higher dosage in females directs differentiation of the ovary (Swain et al., 1998) . Finally, there are several genes which are involved in sex differentiation of the gonad after sex-determination. Mullerian inhibiting substance (MIS), a member of the transforming growth factor-b (TGF-b) superfamily, is expressed in Sertoli cells from 12.5 dpc and causes regeneration of the Muller ducts and possibly apoptosis of meiotic germ cells (Vigier et al., 1987; Behringer et al., 1990; Munsterberg and Lovell-Badge, 1991; Behringer et al., 1994) . Testosterone produced by Leydig cells after 13.5 dpc regulates malespeci®c differentiation of various cells and tissues, including development of the Wol®an duct into the testicular duct.
Genes so far identi®ed and many others to be discovered should form the coordinated chains of interaction and cascades from the sex-determination factors to other transcription factors, which then direct many genes actually working in the cell differentiation and cell-to-cell interaction during development of the testis and ovary. There is very limited knowledge of such interaction among the genes. It is known that Ad4BP/SF-1 can activate MIS expression and P-450 steroid hydroxylases Giuili et al., 1997; Nachtigal et al., 1998) . However, there should be still many other genes, e.g. targets of Sry, transcription factor genes to regulate Ad4BP/SF-1, and genes involved in the interaction between somatic and germ cells.
To identify such genes, we screened a mouse fetal gonad cDNA library by differential hybridization using the subtracted male cDNAs as probes. We obtained a basic helix±loop±helix (bHLH) transcription factor, Pod-1/ Capsulin, which showed an interesting expression pattern during the gonadogenesis. Recently, The functional analysis of Pod-1 gene was reported during the kidney, lung and spleen development (Quaggin et al., 1999; Lu et al., 2000) . However, Pod-1/Capsulin gene seems to have still unknown functions during the gonad development. Analysis of its expression during development of the male and female gonads revealed a complex sex-dependent pattern, which was related but mostly complementary to that of the Ad4BP/SF-1. Moreover, we obtained results that Pod-1/ Capsulin could repress the Ad4BP/SF-1 gene expression.
Results
2.1. Pod-1/Capsulin is related to ABF-1/Musculine/Myo-R and OUT
To isolate genes related to the sex differentiation of the male gonad, we constructed the polymerase chain reaction (PCR)-ampli®ed cDNA pools of the 13.5 dpc male and female gonads (Kanno et al., 1999) . Then, we subtracted the male cDNAs with female cDNAs three times to obtain cDNAs enriched with male-speci®c genes.
The subtracted male cDNAs and the cDNAs from the female gonad were used as probes for differential screening of a cDNA library constructed from 11.5±13.5 dpc gonads of both the male and female. We obtained three independent Pod-1/Capsulin genes (Quaggin et al., 1998; Lu et al., 1998; Hidai et al., 1998) by the differential screening. We con®rmed that expression of Pod-1/Capsulin was stronger in the male than female in the 13.5 dpc mouse gonads (Fig.  1) . Pod-1/Capsulin was most closely related to the bHLH genes that have inhibitory functions, such as ABF-1/Musculine/Myo-R and OUT (Massari et al., 1998; Robb et al., 1998; Lu et al., 1999; Narumi et al., 2000) .
Expression pattern of Pod-1/capsulin
We carried out northern blotting to examine expression of Pod-1/Capsulin in the gonad of mouse fetuses and adults. At 13.5 dpc, Pod-1/Capsulin was expressed at higher levels in the testis than ovary (Fig 2A) . In 3-month-old adults, Fig. 1 . (A) Dot blot analysis using Pod-1/Capsulin cDNA. Pod-1/Capsulin probe hybridized strongly to the male and subtracted cDNAs but weakly to the female cDNAs. F, male cDNAs; C, female cDNAs; S, subtracted cDNAs. (B) Expression of Pod-1/Capsulin in the male gonad was stronger than that in the female gonad at 13.5 dpc as shown by whole-mount in situ hybridization. M, male gonad; F, female gonad.
expression of Pod-1/Capsulin was drastically decreased in the testis, while it was increased in the ovary, showing an opposite sex-dependent pattern in adults compared with fetuses ( Fig. 2B ). Expression in other organs was similar between the adults and fetal stage (data not shown); expressed in the kidney, heart and stomach, but not in the brain, liver and skeletal muscle.
Then, we examined the time course of Pod-1/Capsulin expression in the male and female gonads from 13.5 dpc to postnatal stages. In the testis, the higher expression was sustained during fetal stages (data not shown), but gradually decreased to a lower level during neonatal stages until 3 weeks, then stayed at a weak level from 4 weeks to the adult stage (Fig. 2C) . In contrast, expression in the ovary was at a lower level during fetal stages and until 2 weeks postnatal but increased to higher levels from 3 weeks to the adult stage (Fig. 2D) . Thus, relative expression levels of the male and female gonads were reversed at 2±3 weeks after birth.
Expression patterns of Pod-1/Capsulin in 8.5±9.5 dpc mouse embryos were reported (Lu et al., 1998) . We examined the expression pattern of Pod-1/Capsulin in 10.5 dpc mouse embryos by whole-mount in situ hybridization. At 10.5 dpc, strong expression was observed in the urogenital ridge and mesentery near the urogenital ridge (Fig. 3C) . It was also expressed in the branchial arches and epicardium but at lower levels than that of the urogenital ridge, which later gives rise to gonadal, adrenal and renal tissues. Based on the known roles of Ad4BP/SF-1 and WT-1 in gonadogenesis, we compared their expression with that of Pod-1/ Capsulin during the urogenital development from 9.5 to 11.5 dpc. The expression patterns of Ad4BP/SF-1, WT-1 and Pod-1/Capsulin showed similarities at these early stages of the urogenital development (Fig. 3) . Ad4BP/SF-1, WT-1 and Pod-1/Capsulin were co-expressed in the AGM region at 9.5±10.5 dpc and the gonad at 11.5 dpc. We did not detect any differences between the male and female in the expression of Pod-1/Capsulin at these stages.
Then, we carried out in situ hybridization using cryosections of various tissues. At 13.5 dpc, Pod-1/Capsulin was expressed in the kidney, adrenal gland, lung, heart, intestine and gonad, in agreement with the recent reports (Quaggin et al., 1998; Lu et al., 1998; Hidai et al., 1998) . In the male gonad, Pod-1/Capsulin-expressing cells were found in the tunica albuginea and interstitial region between the testis cords at 13.5 dpc (Fig. 4A,J) . Such expression in the interstitial region was similar to that of Ad4BP/SF-1 (Fig. 4E,K) . In contrast, signals of the MIS expression was observed inside the testis cord as expected from the expression of MIS by Sertoli cells (Fig. 4I,L) . In the female gonad, weaker expression was observed diffusely throughout the ovary (Fig. 4B) . Later, at 15.5 dpc, Pod-1/Capsulin-expressing cells were detected in the female gonad, and they were probably follicle and/or interstitial cells between oocytes (Fig. 4D) . Expression was also detected in the mesonephros, but there was no sex-dependent difference.
To ®nd out whether the Pod-1/Capsulin expression is overlapping with or distinct from that of Ad4BP/SF-1, we carried out double-labeled in situ hybridization using digoxygenin-labeled Pod-1/Capsulin cRNA and¯uorescein-labeled Ad4BP/SF-1 cRNA. In the genital ridge at 10.5 dpc, Pod-1/Capsulin was expressed in the coelomic epithelial cells and mesonephric mesenchymal cells (Fig. 5A) . In contrast, signals of Ad4BP/SF-1 expression were observed in the epithelial-like cells that later form the inner part of gonads. A similar expression pattern was observed at 11.5 dpc (Fig. 5B) . However, there were Pod-1/Capsulin-positive cells dispersed in the inner region. At 17.5 dpc, Pod-1/ Capsulin expression was found in the coelomic epithelial cells, peritubular myoid cells and epithelial-like cells (Fig.  5C ). In contrast, the Ad4BP/SF-1 signals were observed in the Leydig cells and Sertoli cells. These expression patterns were complementary to each other, and even with the detailed examination at higher magni®cations, doublelabeled cells were not detectable at these stages. Also, Pod-1/Capsulin-expressing cells were different from those of Ad4BP/SF-1 in the 15.5 dpc ovary (data not shown).
We examined the expression of Pod-1/Capsulin in the postnatal mouse testis. At 10 days postnatal, Pod-1/Capsulin began to be expressed in Sertoli cells (Fig. 6A) . Sertoli cells also expressed Ad4BP/SF-1 and MIS (Fig. 6B,C) . At 30 days postnatal, however, no signal of Pod-1/Capsulin or Ad4BP/SF-1 were detectable in the Sertoli cells (data not shown). Thus, Pod-1/Capsulin and Ad4BP/SF-1 were coexpressed in Sertoli cells for a short postnatal period. Pod-1/ Capsulin expression was observed in the developing granulosa cells and oocytes in the adult ovary (data not shown).
Transfection assay
Previous studies have indicated that there is an E-box in the promoter region of the Ad4BP/SF-1 gene. Mutagenesis study of this E-box region indicated its importance in the transcriptional regulation, thus suggesting roles of bHLH genes in the sex-dependent regulation of Ad4BP/SF-1 expression (Nomura et al., 1995) . These facts and the mostly complementary expression patterns of Pod-1/Capsulin and Ad4BP/SF-1 suggest an interesting possibility that the Pod-1/Capsulin protein binds to the E-box of Ad4BP/SF-1 and represses its expression during the gonad development. We examined such possibility by a transient transfection experiment using a CAT reporter gene under the control of the Ad4BP/SF-1 promoter (Ad4ECAT0.8K) and a Pod-1/ Capsulin expression construct (Fig. 7) . Our results indicated that Pod-1/Capsulin repressed the transcription from the Ad4ECAT0.8K reporter gene in the I-10 cell line, which had been derived from the Leydig cells and expressed Ad4BP/SF-1 but not Pod-1/Capsulin. Co-transfection of Pod-1/Capsulin and the reporter construct with a mutated E-box (Ad4ECAT0.8KM) failed to show the repression. The same results were obtained when these constructs were co-transfected to the Y-1 cell line, which had been derived from the adrenocortical cells (data not shown). In the same experiments, another bHLH gene, Mash-1 could not activate or repress expression of the reporter genes. Thus, Pod-1/Capsulin could speci®cally repress expression of the reporter gene which carried the upstream regulatory region of the Ad4BP/SF-1 gene.
To ®nd out whether the expression of Pod-1/Capsulin affects the endogenous Ad4BP/SF-1 expression, Pod-1/ Capsulin or Mash-1 was expressed under the CMV promoter in I-10 cells (Fig. 8) . Ad4BP/SF-1 and G3PDH mRNAs were assayed by Northern blotting 2 days after the transfection. Ad4BP/SF-1 expression was downregulated by such forced expression of Pod-1/Capsulin. In contrast, Mash-1 did not affect the Ad4BP/SF-1 expression.
Discussion

Pod-1/Capsulin, a bHLH gene related to MyoR/ Musculin/ABF-1 and OUT
The bHLH family of transcription factors are known to regulate a variety of developmental programs such as neurogenesis and myogenesis, and many of them are known to play important roles in cell differentiation, speci®cation and morphogenesis. They include E12 (Murre et al., 1989a) , Nmyc (DePinho et al., 1986) , MyoD (Davis et al., 1987) , myogenin (Edmondson and Olson, 1989; Wright et al., 1989) , NeuroD (Lee et al., 1995) , neurogenin (Ma et al., 1996) and Mash1 (Johnson et al., 1990) . The HLH genes involved in the sex differentiation are known only in Drosophila, including daughterless (Caudy et al., 1988; Cronmiller et al., 1988) , sisterless b (Villares and Cabrera, 1987) , deadpan (Bier et al., 1992) and extramacrochaetae (Ellis et al., 1990; Garrell and Modolell, 1990) . They regulate the expression of Sex-lethal, which plays a pivotal role in sex Fig. 3 . Whole-mount in situ hybridization to show expression patterns of Pod-1/Capsulin in the urogenital region at 9.5 dpc (A), 10.5 dpc (C) and 11.5 dpc (E) during development of the urogenital ridge and gonad. Expression patterns of WT-1 at 9.5 dpc (B) and that of Ad4BP/SF-1 at 10.5 dpc (D) or 11.5 dpc (F) are also shown for comparison. g, genital ridge; ug, urogenital ridge. determination in Drosophila (Cline, 1993; Hoshijima et al., 1995) . The bHLH proteins usually form heterodimers between the tissue-speci®c class B and more ubiquitous class A molecules (Murre et al., 1989b) . The dimers bind to the E-box in the promoter region of target genes to regulate their transcription.
The bHLH genes can be classi®ed into a few groups; neural genes including NeuroD and neurogenin, muscle differentiation genes including MyoD and myogenin, and those expressed in the mesodermal cells including paraxis (also known as bHLH-EC2 or Meso-1; Burgess et al., 1995; Quertermous et al., 1994; Blanar et al., 1995) and scleraxis (Cserjesi et al., 1995a,b) . Homology analysis of the bHLH domain of the Pod-1/Capsulin protein indicated that it is related to the Paraxis, Scleraxis, dHAND and eHAND proteins, and it is consistent with the expression of Pod-1/ Capsulin in various mesodermal tissues. Moreover, bHLH domain of the Pod-1/Capsulin protein is most closely related to the recently investigated ABF-1/Musculin/Myo-R and OUT, which have repressive activities (Massari et al., 1998; Robb et al., 1998; Lu et al., 1999; Narumi et al., 2000) .
Expression pattern of Pod-1/Capsulin
Expression of Pod-1/Capsulin ®rst appear at 8.5 dpc in the mesodermal cells of anterior and posterior parts of embryos with weaker expression in the middle part (Lu et al., 1998 and our unpublished results). The anterior expression seemed to coincide with the pharyngeal pouch mesenchyme. The posterior expression is strong in the mesodermal cells around the base of allantois, and the expression is maintained until this region forms the urogenital ridge. Thus, Pod-1/Capsulin may have multiple functions in the development and differentiation of various mesodermal tissues and organs as reported previously (Quaggin et al., 1998; Lu et al., 1998; Hidai et al., 1998) .
At later stages of fetal development, most pronounced expression of Pod-1/Capsulin is observed in the kidney and gonad. Pod-1/Capsulin is expressed in the kidney persistently from the primordium stage to later stages (Quaggin et al., 1998) . On the other hand, our present study revealed that expression in the gonad showed a complex pattern dependent not only on the sex of fetuses but also on developmental stages. At 11.5 dpc, the expression was at the same level in the male and female gonads, but it became stronger in the male than female at 13.5 dpc. Since the initial determination of testis development is signaled by Sry expression at 10.5±11.5 dpc (Hacker et al., 1995) , the sex-dependent expression pattern of Pod-1/ Capsulin is one of early events in the sex differentiation of the gonad. The higher level of Pod-1/Capsulin expression in the testis persisted during later fetal stages, but it declined slowly during neonatal stages until 20 days after birth, that coincides with progression of the ®rst wave of the meiosis and spermatid formation in the testis. In contrast, Pod-1/ Fig. 4 . Expression of Pod-1/Capsulin mRNA in the embryonic mouse gonad. Cryosections were hybridized with anti-sense cRNA probes for Pod-1/Capsulin (A±D,J), Ad4BP/SF-1 (E±H,K) or MIS (I). Male gonads 13.5 dpc (A,E,I±L), 13.5 dpc female gonads (B,F), 15.5 dpc male gonads (C,G) and 15.5 dpc female gonads (D,H) are shown. Control hybridization using sense-strand probes for Pod-1/Capsulin gave no signi®cant signal (data not shown). is, interstitial cells; m, mesonephros; tc, testis cords. Scale bars: 260 mm (A,B,D,E,F,H,I); 320 mm (C,G); 65 mm (J,K,L).
Capsulin expression in the ovary increased after birth and became stronger than the testis by 3 weeks after birth.
Such complex expression pattern in the male and female gonads is similar to that of Ad4BP/SF-1, whose expression starts at the same level in the male and female gonads at 11.5 dpc and becomes stronger in the male than female at 13.5 dpc. Then, after birth, the expression level increases in the ovary to surplus testis (Hatano et al., 1994) . Ad4BP/SF-1 was ®rst identi®ed as a transcription factor controlling the steroidogenesis, and it is expressed in Leydig cells and Sertoli cells of the testis Ikeda et al., 1993; Morohashi et al., 1993; Ikeda et al., 1994) . In contrast, our present study indicated that Pod-1/Capsulin was expressed in the coelomic epithelial cells, peritubular myoid and epithelial-like cells. In addition, our present in situ hybridization study indicated that the expression pattern Fig. 5 . Expression patterns of Pod-1/Capsulin and Ad4BP/SF-1 in the gonads at 10.5 dpc (A), 11.5 dpc (B) or 17.5 dpc (C). Cryosections were double-hybridized with anti-sense cRNA probes for Pod-1/Capsulin (purple) and Ad4BP/SF-1 (orange). Scale bars: 50 mm. . CAT assay using Pod-1/Capsulin, Mash-1 and Ad4CAT plasmids in the I-10 cell line. Relative CAT activities are shown as ratios to the CAT activity of the Ad4CAT0.8K only. Structures of Ad4CAT0.8K (wild-type E-box) and Ad4CAT0.8KM (mutated E-box) have been described previously (Nomura et al., 1996) .
of Pod-1/Capsulin in the fetal testis was closely related but mostly complimentary to that of Ad4BP/SF-1, thus suggesting important interaction between the two genes.
Possible function of Pod-1/Capsulin in the gonads
Pod-1/Capsulin is the ®rst class B bHLH transcription factor whose expression pattern is sex-and stage-dependent during gonadogenesis. Also, Pod-1/Capsulin appears to be one of the earliest genes expressed in the mesodermal cells that later form the gonad. In the mouse, various members of the transcription factors have been demonstrated to play important roles in the urogenital system. Functional analysis using several mutant mouse strains generated by the gene disruption of Ad4BP/SF-1, WT-1, Pax-2 and Emx-2 demonstrated that these genes are essential for formation of the urogenital system (Luo et al., 1994; Kreidberg et al., 1993; Torres et al., 1995; Miyamoto et al., 1997) . A striking phenotype was reported for the Ad4BP/SF-1 mutant, which completely lacks the gonad and adrenal.
Previous studies have indicated the presence of the E-box sequences in the promoter region of Ad4BP/SF-1 and their importance in its transcriptional regulation (Nomura et al., 1995) , thus indicating roles of bHLH genes in the sexdependent regulation of Ad4BP/SF-1 expression. Lu et al. (1998) have demonstrated that the Capsulin/Pod-1 protein can heterodimerize with E12 and bind to the E-box consensus sequence. Furthermore, E12 was expressed in the developing gonad and testis (Tamura and Nakatsuji, unpublished data) . These facts and the expression pattern of the two genes suggest an interesting possibility that the Pod-1/ Capsulin represses the expression of Ad4BP/SF-1. Our CAT assay and forced expression analysis indeed supported this hypothesis. MyoR, which is most closely related to Pod-1/Capsulin, is suggested to play a role as a lineage-restricted transcriptional repressor of the muscle differentiation program (Lu et al., 1999) . In the development of the fetal gonad, Pod-1/Capsulin may have a function in cell speci®-cation through regulation of Ad4BP/SF-1 expression, in a similar way to MyoR in the muscle development. There are at least three possible mechanisms whereby Pod-1/Capsulin can repress Ad4BP/SF-1 expression. First, Pod-1/Capsulin dimer may bind to the E-box in the Ad4BP/SF-1 control region and actively repress transcription through its transcriptional repression domain. Second, it may compete with another bHLH/E-protein heterodimer for the E-box binding site in the Ad4BP/SF-1 control region. Third, Pod-1/Capsulin may compete with another bHLH protein for limiting quantities of E-protein dimerization partners. Further investigation on interaction between Pod-1/Capsulin and Ad4BP/SF-1 is necessary to clarify this point.
Gene cascades from the Sry expression bring about differentiation of seminiferous tubules in the testis and mitotic arrest of the prospermatogonia, instead of the initiation of meiosis and differentiation of oocytes in the ovary. Such events should include many genes working in various parts of the cell differentiation, tissue morphogenesis, and interaction between the germ and somatic cells. Analysis of such gene cascades, so far, has revealed a few aspects, such as the activation of MIS by Ad4BP/SF-1 and WT-1 Giuili et al., 1997; Nachtigal et al., 1998) and repression of steroidogenesis by Dax-1 (Zazopoulos et al., 1997) . There are still many aspects remaining to be examined, and further investigation of the function of Pod-1/ Capsulin may help to resolve the molecular mechanisms of the mammalian sex differentiation.
Experimental procedures
Mouse embryos
ICR mice were purchased from SLC, Japan and maintained in a room with the light period of 07:00±19:00 h. Embryos were obtained from natural mating. Noon on the day when the vaginal plug was detected was designated as 0.5 dpc.
Expression analysis
Northern blotting was performed as described before (Tamura et al., 1994) . Total RNA was isolated from the adult tissues by the AGPC method (Chomczynski and Sacchi, 1987) . For the embryonic tissues and cultured cells, we used the RNeasy total RNA isolation kit (Qiagen). A sample of 15 mg of total RNA was loaded onto each lane and blotted on Hybond-N 1 nylon membrane (Amersham).
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P-Labeled probes were prepared using BcaBEST labeling system (TaKaRa). The full-length Pod-1/Capsulin insert, Fig. 8 . Northern blotting analysis to show effects of the forced expression of Pod-1/Capsulin or Mash-1 in the I-10 cell line. Amounts of Ad4BP/SF-1 mRNA are shown as ratios to that of the untransfected I-10 cells. G3PDH was used as an internal control.
